The reciprocal chromosomal translocation t(4;11) is correlated with infant, childhood, adult and therapyrelated high-risk acute leukemia. Here, we investigated the biological effects of MLL . AF4, AF4 . MLL or the combination of both reciprocal fusion proteins in a conditional in vitro cell culture model system. Several parameters like cell growth, cell cycling capacity, apoptotic behavior and growth transformation were investigated under physiological and stress conditions. Co-transfected cells displayed the highest resistance against apoptotic triggers, cell cycling capacity and lossof-contact inhibition. These analyses were complemented by gene expression profiling experiments and specific gene signatures were established for each of the three cell lines. Interestingly, co-transfected cells strongly upregulate the homeobox gene Nanog. In combination with Oct4, the Nanog homeoprotein is steering maintenance of pluripotency and self-renewal in embryonic stem cells. Transcription of Nanog and other stem cell factors, like Oct4 and Bmi1, was verified in biopsy material of t(4;11) patient cells which express both reciprocal t(4;11) fusion genes. In conclusion, the presence of both reciprocal MLL fusion proteins confers biological properties known from t(4;11) leukemia, suggesting that each of the two fusion proteins contribute specific properties and, in combination, also synergistic effects to the leukemic phenotype.
Introduction
Chromosomal translocations t(4;11) are the most frequent chromosomal aberration of the MLL gene and are correlated with infant, childhood, adult and therapy-related acute lymphoblastic leukemia (Felix et al., 1995;  for a review see Mitterbauer-Hohendanner and Mannhalter, 2004) . In particular, t(4;11) patients have a poor prednisone response (Dordelmann et al., 1999) and are therefore stratified according to high-risk acute leukemia protocols (Pui et al., 1994) .
Although t(4;11) translocations are associated with such a severe disease phenotype, no animal model is currently available that phenocopies the human disease. By using the inverter mouse model and an AF4 knock-in strategy, however, two different transgenic MLL . AF4 mouse models have been established recently. Both developed a disseminated large B-cell lymphoma with low penetrance and long latency: about 50% of these mice died of B-cell lymphomas after a median time of 520-540 days Metzler et al., 2006) . This clearly indicated that the MLL . AF4 fusion protein alone does not cause the known t(4;11) disease phenotype. Besides these transgenic attempts, retroviral transduction of the MLL . AF4 fusion gene does not lead to the development of any hematomalignancy (So et al., 2004; Lavau et al., 2004, personal communication) , even though a small number of blast-like replating cells could be obtained in semisolid agar.
Apart from these animal model systems, only a few stable cell lines were established from t(4;11) patients; however, they all differ in their biological properties and their karyotypes (Stong et al., 1985; Lange et al., 1987; Greil et al., 1994) . They are characterized by the expression of lymphatic and myeloid surface antigens (e.g. CD34 þ , CD19 þ , CD13 þ , CD33 þ , CD133 þ , CD10À) and their ability to efficiently block apoptosis under cytotoxic drug treatment (Kersey et al., 1998) . This biological feature may explain the high relapse rate in these leukemia patients. By contrast, overexpression of the MLL . AF4 fusion protein in the myelomonocytic leukemia cell line U937 cells caused cell cycle arrest (Caslini et al., 2004) , whereas siRNA-mediated knockdown of the MLL . AF4 fusion protein in the t(4;11) leukemic cell line SEM led to a strong increase of apoptosis and a reduction in clonogenicity (Thomas et al., 2005) . Overexpression of the reciprocal AF4 . MLL fusion protein in MEF led to a loss-ofcontact inhibition, and thus to growth transformation (Bursen et al., 2004) . All these data sound controversial and did not permit consistent conclusions to be drawn on the pathological disease mechanism(s) of t(4;11) leukemia. Therefore, we aimed to establish an in vitro t(4;11) model system that recapitulates certain aspects of t(4;11) leukemia cells, and thus allows investigation of the specific contribution(s) of each reciprocal MLL fusion protein.
For this purpose, mammalian cells were stably transfected with conditional expression constructs coding for doxycycline-inducible MLL . AF4 and/or AF4 . MLL transgenes. After induction, transfected cells were analysed for their growth properties (cell counts and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay), cell cycling capacity, specific apoptotic rates and growth transformation. In parallel, gene expression profiling experiments were performed to gain insights into up-and downregulated genes due to the presence of either one or both reciprocal MLL fusion proteins. The results obtained suggest that both reciprocal MLL fusion proteins are contributing to the disease phenotype of t(4;11) leukemic cells. Moreover, gene expression profiling experiments revealed the transcriptional upregulation of Nanog and Oct4 in co-transfected cells, whereas singletransfected cells did not show any upregulation of these genes. This novel feature was verified in the biopsy material of t(4;11) patients. Nanog codes for an Antennapedia-class homeobox protein which is -in conjunction with Oct4 and Sox2 -necessary and sufficient for the self-renewal and maintenance of embryonic stem cells (Chambers et al., 2003; Mitsui et al., 2003) . The consequences of these novel findings will be discussed.
Results
Establishing conditional cell lines expressing MLL . AF4, AF4 . MLL or both MLL fusion genes Stably transfected MEF/tTA cell lines (Tet-off) were generated by transfecting them with the above mentioned expression constructs. Single-cell clones were selected under appropriate conditions and tested for their ability to induce their transgene(s) (data not shown). Inducible cell clones were chosen and used throughout the experiments. As shown in Figure 1a , a doxycycline-dependent increase in transcription could be demonstrated for all transgenes after withdrawal of doxycycline (À). Time course experiments revealed expression of the resulting fusion proteins after 3-5 days (data not shown). Therefore, all subsequent experiments were performed after 5 days of transgene induction in order to generate consistent data sets. Expression of both MLL fusion proteins at day 5 is shown in Figure 1b to demonstrate full-length protein expression of MLL . AF4 and AF4 . MLL in all three clones used throughout this study.
Cell growth, specific apoptosis and cell cycle analysis of single-and co-transfected cells under normal conditions and serum deprivation All cell clones were grown in the absence of doxycycline for 5 days and investigated under normal cell culture conditions (Dulbecco's modified Eagle's medium (DMEM)/10%fetal calf serum (FCS)/1% Pen-Strep). A significantly higher growth rate was observed for cotransfected cells, followed by untransfected MEF/tTA cells and AF4 . MLL-transfected cells. Nearly no growth was observed for MLL . AF4-transfected cells, indicating that these cells are inhibited in their growth potential (Figure 2a, see below) . Noteworthy, AF4 . MLL-transfected and co-transfected cells displayed significantly higher growth rates according to the data obtained by the MTT assay, but the net growth of AF4 . MLLtransfected cells seems to be compromised due to a higher apoptosis rate (2-20% over the observation period; see below). All other cell lines displayed an apoptosis rate below 3% under these cell culture conditions (Figure 2b ). The MTT assays revealed that the MEF/tTAHder11 cells displayed significantly lower growth rates than the MEF/tTAHder4 and the MEF/ tTAHder4/11 cell lines, respectively. It was also obvious that untransfected control cells and MLL . AF4-transfected cells seem to reduce their growth rates when confluency was reached, whereas AF4 . MLL-and cotransfected cells displayed increasing growth rates which reflect their 'loss-of-contact inhibition' (Figure 2c ; see also below: Focus formation experiments). . MLL (der4), MLL . AF4 (der11) or both (der4/11); protein expression was induced by omitting doxycycline in the growth media for 5 days. Upper panel: expression of the AF4 . MLL fusion protein; middle panel: expression of the MLL . AF4 fusion protein; lower panel: b-actin loading controls. Transfected cell lines were treated with MG132 to stabilize the expression of the full-length AF4 . MLL fusion protein (328 kDa) that otherwise would be degraded via the proteasomal pathways due to its ability to interact with the E3-ligases SIAH1 or SIAH2, respectively (Bursen et al., 2004) .
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We next investigated all cell lines in serum-free media (DMEM/1% Pen-Strep) to investigate their capability to cope with stress situations. All transgenes were induced again for 5 days in the absence of doxycycline and then cultured in serum-free media. All subsequent experiments were repeated three times in triplicate. As shown in Figure 2d -f, cell growth, specific apoptosis rates, and cell cycle analysis were performed over a time period of 24-96 h. Co-transfected cells displayed the lowest decrease of cell numbers under these conditions (B28% reduction after 96 h). However, even the singletransfected cells had only a reduction of 35-39% and differed significantly from control cells that displayed a 70% reduction of cell numbers ( Figure 2d ). As summarized in Figure 2e , the specific apoptosis rate of control MEF/tTA cells was between 2 and 33% (24-96 h), whereas the MEF/tTAHder11 clone showed a lower apoptotic rate in the range between 2 and 23%. Highest rates were observed again for the MEF/ tTAHder4 clone that displayed apoptotic rates between 2 and 43% over the observation period. By contrast, cotransfected MEF/tTA cells displayed the lowest level of apoptosis in the range between 2 and 21%. As summarized in Figure 2f , untransfected MEF/tTA cells mostly arrested in G0 (86-93% over 24-96 h). The MEF/tTAHder11 clone displayed arrested cells in the range of 54-77% (24-96 h). The MEF/tTAHder4 clone displayed an even lower G0-rate between 52 and 68% during the observation period. Co-transfected cells had a stable G0-rate between 77 and 81%, but still exhibited 23-19% of cycling cells.
Focus formation experiments
All cell lines were seeded in small Petri dishes (1 Â 10 4 cells) and grown in the absence or presence of doxycyline for 21 days. All cells were formalin-fixed and stained with methylene blue solution. As shown in Figure 3 , in the presence of doxycycline (absence of transgene (a) DDC(t) data of p16, p18, p21 and p27. Significant changes were observed for p16 in MLL . AF4-(der11)-transfected cells. p21 and p27 were significantly lower in co-(der4/11)-transfected cells.
(b) DDC(t) data of Bim, Bid, Bax, Bak, Bcl2 and BclXL. Bim, Bid and Bcl2 were significantly lower in co-(der4/11)-transfected cells.
Bax is relatively higher in AF4 . MLL-(der4)-transfected cells.
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Surprisingly, all analysed pro-and antiapoptotic genes displayed lower transcription rates in the transfected cell lines (25-95% decrease) when normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (the GAPDH mRNA levels were equal for all transfected and untransfected cells as judged by the DC(t) values). In MEF/tTAHder4 cells, a relative activation of Bax was observed when compared to the other transfected cell lines. The observed reduction of apoptosis in the co-transfected MEF/tTAHder4/11 cell line may presumably be explained by the very low expression of Bim (0.0570.003) and Bid (0.0670.002), both activators of Bax and Bak (Figure 4b ). However, these data did not give a satisfactory explanation for the observed effects.
Gene expression profiling experiments using single-and co-transfected cells All cell clones were grown under optimal conditions without doxycycline for 5 days and total RNA was isolated. All RNA preparations were independently repeated three times and mixed to eliminate biological fluctuations. The RNA pools were tested for endogenous house keeping genes and optimal RNA quality. Affymetrix chip experiments were performed twice by using Mouse Genome 430 2.0 arrays. Subsequent hybridization experiments showed a total expression of about 48% for all spotted genes in both experiments. All transfected cell lines were compared to the untransfected MEF/tTA cell line. As shown in Figure 5a , a total of 562 differentially expressed genes were observed in the MEF/tTAHder11 cell clone (2-to 146-fold differences in gene expression; 399 genes were upregulated and 163 genes were downregulated). The identified genes belong to the following ontogenetic groups: cell adhesion, cell communication, organ development, organ morphogenesis, response to external stimuli, defense response, extracellular matrix/structure organization and biogenesis, and morphogenesis. The MEF/tTAHder4 clone exhibits a total of 660 differentially expressed genes (2-to 398-fold differences in gene expression; 552 genes were upregulated and 108 genes were downregulated). The identified genes belong to the following ontogenetic groups: cell adhesion, cell communication, defense response, sulfur metabolism and homophilic cell adhesion. The co-transfected MEF/tTAHder4/11 clone displayed 800 differentially expressed genes (2-to 150-fold differences in gene expression; 677 genes were upregulated and 123 genes were downregulated). The identified genes belong to the following ontogenetic groups: cell adhesion, cell communication, organismal physiological processes, organ morphogenesis, organ development, immune response, defense response, cell-cell adhesion, odontogenesis and skeletal development.
As shown in Figure 5a , the data sets displayed intersections of overlapping gene expression patterns between all three clones. Of interest, about 60% of all genes identified in the MEF/tTAHder4 clone are shared with the co-transfected MEF/tTAHder4/11 clone, whereas in MEF/tTAHder11 cells only a very few genes are shared with the other two clones. Moreover, all three clones displayed individual gene signatures that discriminated the clones from each other (MLL . AF4: 337 genes; AF4 . MLL: 234 genes; co-transfected cells: 359 genes). The gene signatures A-G are listed in Supplementary Tables A-G respectively. Interestingly, the MEF/tTAHder11 cells displayed the overexpression of only two Hox genes: HoxA7 was 3.3-fold overexpressed whereas HoxA10 was 6.1-fold overexpressed. No evidence for HoxA9 or Meis-1 overexpression was found when compared to untransfected control cells. Surprisingly, the HoxA7-and HoxA10-specific signature disappeared in the co-transfected MEF/tTAHder4/11 cells. However, co-transfected (3) and Nanog (4) were compared; the precise numbers and percentages of identified genes are listed.
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A Gaussmann et al cells seem to overexpress the homeobox gene Nanog 16-fold. Nanog was identified as the key component to maintain the pluripotency of the embryonic stem, together with Oct4 and Sox2 (Boyer et al., 2005; Loh et al., 2006) . Nanog/Oct4 expression confers selfrenewal in a leukemia inhibitory factor (LIF)/STAT3-independent manner and blocks specifically all differentiation processes (Mitsui et al., 2003) . Next, we compared the data sets of all three lines with gene expression profiling data sets derived from the analysis of Mll k.o. cells (Yu et al., 1995) and a recently published DSET mutant of Mll (Terranova et al., 2006) . The latter MLL mutant has viable offspring but does not exhibit the histone H3K4 methyltransferase activity. Mll k.o. cells displayed 1.991 deregulated genes (2-to 781-fold differences in gene expression; 1.171 genes were upregulated and 820 genes were downregulated), whereas Mll DSET cells revealed 1.560 deregulated genes (2-to 333-fold differences in gene expression; 643 genes were upregulated and 917 genes were downregulated). The co-transfected MEF/tTAHder4/11 clone shares 254 target genes with Mll k.o. cells and 204 target genes with Mll DSET cells (overlap of 31 and 26%). The same was true for MEF/tTAHder4 that shared 225 and 170 target genes with both MLL mutant strains (overlap of 34 and 26%; Figure 5b ). Single-transfected cells expressing the MLL . AF4 transgene shared 185 and 156 genes with Mll k.o. and Mll DSET cells (overlap of 33 and 28%; Figure 5b ). Thus, all transfected cells shared a significant portion of their deregulated genes (26-34%) with genes deregulated by knocking out (functions of) the MLL gene. This may indicate that the presence of t(4;11) fusion proteins in the single-and co-transfected clone mimic, in part, an Mll k.o. phenotype, presumably due to a competitive situation between the MLL multiprotein complex and the protein complexes forming upon the two reciprocal MLL fusion proteins.
We next compared gene sets A-G with primary MLL target genes that were recently identified by a ChIP-on-CHIP experiment using antibodies against MLL protein (2.420 genes; Guenther et al., 2005) . There is a median overlap of 9% with these MLL target genes, indicating that the established gene sets A-G represent a small fraction of primary MLL target genes (Figure 5b ), whereas non-overlapping genes observed in the gene expression profiles presumably reflect secondary target genes.
One of the top-scoring genes identified in the cotransfected clone was Nanog. This gene is upregulated about 16-fold, whereas any of the single-transfected cells did not show any differences in Nanog transcription. We have to mention that there are 11 pseudogenes of Nanog that differ by distinct point mutations, small deletions and frameshifts. However, two of them are so-called retrogenes (Nanog P8, P10) that encode proteins with a 99% identity to the bona fide Nanog protein (Booth and Holland, 2004) . The Nanog P8 retrogene is biological, functional and able to substitute for the functions of the bona fide Nanog protein . All the other pseudogenes encode C-terminal truncated versions of the Nanog protein.
To gain confidence that there is biological activity of Nanog in the co-transfected cell line, we first compared the MEF/tTAHder4/11 gene expression profile with an available Nanog data set obtained by another ChIP-on-CHIP experiment (1.409 genes; Boyer et al., 2005) . There is a median overlap of 6% with Nanog target genes, indicating that established gene sets A-G represent a tiny fraction of primary Nanog target genes (Figure 5b) .
A total of 30, 46 and 55 Nanog target genes were identified in MLL . AF4-, AF4 . MLL-and co-transfected cells, respectively. The highest percentages of Nanog target genes were identified for gene sets C, F and G that define target genes idiosyncratic for AF4 . MLL-, co-transfected cells and genes shared by AF4 . MLL-and co-transfected genes. This may indicate that the presence of AF4 . MLL or of both MLL fusion proteins is presumably key to activating the Nanog gene or one of its retrogenes.
All data sets obtained from the three cell lines were selectively analysed for the presence of genes involved in transcription, chromatin modification, signaling, cell cycle, apoptosis and DNA repair. As summarized in Table 1 , we first analysed deregulated transcription factors. A small fraction is shared in all three cell lines (underlined). Each cell line displays a series of (mostly upregulated) transcription factors. Forty transcription factors were identified in co-transfected cells (33 upregulated, 7 downregulated), whereas MLL . AF4-and AF4 . MLL-transfected cells displayed 33 and 36 deregulated transcription factors, respectively (MLL . AF4: 26 upregulated, 7 downregulated; AF4 . MLL: 30 upregulated, 6 downregulated). Seven transcription factors were deregulated in all three lines (Id4, Egr3, Asb5, Fos, Hdac9, Hey1 and Trib3).
Each cell line also displayed transcription factors that are controlled by the core Nanog network (MLL . AF4: 1; AF4 . MLL: 4; co-transfected: 5; marked in bold or bold italics). However, only AF4 . MLLand co-transfected cells exhibit Nanog targets that are transcriptionally activated by the core Nanog network (Jarid2, Nanog, Stat3, Zfp36l1 and Zic3), while the only core Nanog target gene identified in MLL . AF4-transfected cells, the segment polarity gene Engrailed, is normally repressed by the core Nanog network. The same was true for co-transfected cells that express the potent oncogene Fli1, normally repressed in Nanog-expressing cells. The expression of these target genes may indicate that they are either not repressed by the Nanog system or arbitrarily activated by the presence of the t(4;11) fusion proteins. Table 2 summarizes the overlapping transcription, chromatin modification, signaling, cell cycle, apoptosis and DNA repair genes of the established cell lines versus target genes identified by gene expression profiling experiments using the Mll k.o. strain, the Mll DSET mutant strain, or primary target genes identified by ChIP-on-CHIP experiments performed by others using anti-MLL or anti-Nanog antibodies (Boyer et al., 2005; Guenther et al., 2005) .
Confirmation of Nanog expression in biopsy material of t(4;11) patients
To verify ectopic Nanog expression in t(4;11) leukemic cells, we next analysed Nanog transcription in biopsy material of adult and pediatric t(4;11) patients. We have chosen only t(4;11) patients that were positively analysed for the presence of both reciprocal MLL fusion alleles (MLL . AF4 þ /AF4 . MLL þ patients). As shown in Figure 6 , all 14 t(4;11) patients (10 adult, 4 pediatric patients) displayed transcription of the Nanog gene (or of full-length retrogenes such as Nanog P1 or Nanog P8). Moreover, t(4;11) patient cells showed active transcription of Oct4 and Bmi1, two genes selectively expressed in stem cells. However, no transcriptional activity was found for Sox2, the third component identified in the core Nanog network (Boyer et al., 2005; Loh et al., 2006) . Sox2 is a minor-groove DNA binding protein that is involved in the transcriptional activation of the Nanog gene, but is presumably dispensable if Nanog (or a retrogene thereof) is already transcriptionally active. Several target genes of the core Nanog network were also investigated (Stat3, Myst3, REST, ZFP36L1, Meis1, Fli1, Pax6, ESX1L). All tested downstream target genes of the core Nanog network were found to be transcriptionally active in t(4;11) patient cells. This indicated that the observed transcripts of Nanog and Oct4 in t(4;11) patient cells were coding for functional proteins, sufficient to initiate and maintain transcription of genes known to belong to the stem cell compartment. In conclusion, the observed transcription of Nanog (or of functional Nanog retrogenes) in conjunction with Oct4, resulting in a stem-cell-like activity, is presumably an important and novel feature of t(4;11) leukemia.
Discussion
We established a conditional 'in vitro t(4;11) model system' to study certain aspects of t(4;11) biology. We could show that both t(4;11) fusion proteins exhibit oncogenic properties. The MLL . AF4 fusion protein increases resistance against apoptosis (which is dominant over AF4 . MLL), whereas the AF4 . MLL fusion protein is able to growth transform cells (which is dominant over MLL . AF4). Single-transfected t(4;11) fusion proteins were able to affect cell growth and cell cycling. However, the co-transfected cell line displayed the highest growth rate, maintained cell cycling in the The presented data are in line with all yet published data. Co-transfected MEF/tTAHder4/11 cells displayed a higher resistance against apoptosis, comparable with data obtained in another study, demonstrating that t(4;11) cell lines have the highest resistance against druginduced apoptosis when compared with cells expressing other leukemogenic gene fusions (Kersey et al., 1998) . A lower expression of the antiapoptotic Bcl-2 protein in MLL . AF4-transfected U937 cells has also been described (Caslini et al., 2004) . The upregulation of p16 in MLL . AF4-transfected cells could explain the observed growth inhibition, which is also in line with published data (Caslini et al., 2004) . It has already been shown that the MLL . AF4 fusion protein directly binds to the promoter regions of two cell cycle inhibitors, p18 and p27, and regulates their gene expression (Xia et al., 2005) . Recently, functional data were obtained from murine embryonic fibroblasts derived from Taspase1 knockout mice (Takeda et al., 2006) . Taspase1-deficient cells and MLL . AF4-transfected cells are both growth inhibited and display overexpression of p16. Thus, cells expressing the MLL . AF4 fusion protein and cells that produce only uncleaved MLL protein behave very similarly.
The AF4 . MLL-single-transfected cell line mimics the situation of t(4;11) SEM cells after downregulation of the MLL . AF4 fusion protein by using an siRNAmediated approach (Thomas et al., 2005) . Transient downregulation of the MLL . AF4 fusion protein resulted in a strong increase of apoptosis, a typical feature identified for the single-transfected MEF/tTAH der4 cells. Assuming that Nanog (or Nanog-like activity) -identified only in the co-transfected cells -is required for clonogenicity, it would explain the observed reduction of the replating efficiency of these siRNAtreated SEM cells (Thomas et al., 2005) . One of the biological features of MLL . AF4-bearing cells is their reduced sensibility against apoptosis. This feature is also reflected by two recently established transgenic mouse model systems using the MLL . AF4 transgene Metzler et al., 2006) . In both mouse models, a B-cell lymphoma phenotype was observed due to the expression of the transgene. However, the disease phenotype had a low penetrance and an extremely long latency (50% lymphomas after a median time of 520-540 days). Frequently, lymphomas derive from germinal center B cells which acquired a block in one of their apoptotic pathways and therefore arbitrarily survived apoptotic triggers due to a selective advantage (e.g. a chromosomal translocation). Assuming that overexpression of MLL . AF4 mimics in part the dominant phenotype of overexpressed antiapoptotic genes (Strasser et al., 1990) , the development of a lymphoma disease phenotype is not unexpected.
In addition, cells of both transgenic mouse models showed neither a differentiation arrest nor the accumulation of immature cells, arguing for a missing second hit. In case of t(4;11) leukemia the missing second hit probably derives from the reciprocal AF4 . MLL fusion allele. Thus, the t(4;11) chromosomal translocation creates two independent hits, which cause enhanced and uncontrolled cell proliferation and resistance against apoptosis at the same time. It has already been shown that Taspase1-mediated proteolysis of the AF4 . MLL fusion protein results in the accumulation of the AF4 . MLL fusion protein and thereby provides important oncogenic functions (Bursen et al., 2004) . The data obtained from the focus formation experiments indicate that this biological property of the AF4 . MLL fusion protein even dominates over the MLL . AF4 Figure 6 Exploring the core Nanog regulatory network in t(4;11) leukemia cells. Upper panel: cDNA obtained from t(4;11) patients were used to identify Nanog transcripts in primary biopsy material from 10 adult and four pediatric t(4;11) leukemia patients (all exhibit both reciprocal fusion alleles). The oligonucleotides amplified a 419 bp Nanog amplimer in all patients. Additional bands: alternative splicing of Nanog exon 4. Other bands (below and above) are derived from expressed Nanog retrogenes. Lower panels: RT-PCR experiments using oligonucleotides specific for Pou5f1/Oct4 (440 bp), Sox2 (398 bp), Bmi1 (451 bp), Stat3 (327 bp), Myst3 (590 bp), ZFP36L1 (449 bp), REST (447 bp), Meis1 (503 bp), Fli1 (441 bp), Pax6 (399 bp), ESX1L (380 bp) and b-actin control (347 bp). In all patients, consistent expression of all genes could be demonstrated. Left: black boxes indicate that these particular genes should be actively transcribed in the presence of functional Nanog/ Oct4; shaded boxes indicate that these particular genes should be transcriptionally repressed in the presence of functional Nanog/ Oct4; white boxes: genes not controlled by the Nanog/Oct4 network. t(4;11) pathobiology A Gaussmann et al fusion protein. In addition, the two reciprocal MLL fusion proteins cooperate in a synergistic manner because co-transfected cells display enhanced properties (growth rate, resistance against apoptosis) or features not observed before in the two single-transfected cell lines (e.g. the downregulation Bim, Bid and Bcl2; downregulation of p21 and p27; transcriptional activation of Nanog, Oct4, Bmi1 and several other oncogenes). One important finding is the transcriptional upregulation of Nanog (or Nanog-like transcripts) in cotransfected cells. Ectopic expression of Nanog leads to dedifferentiation and blocks further developmental processes (Taranger et al., 2005) . Malignant transformation of teratocarcinomas and germline tumors are caused by ectopic expression of Nanog (Almstrup et al., 2004; Hoei-Hansen et al., 2005; Skotheim et al., 2005) . Overexpression of the full-length retrogene Nanog P8 has been identified in a large variety of different solid tumors or cancer cell lines . This finding also sheds light on the ongoing discussion about cancer stem cells (Jordan et al., 2006) . Systematic analysis of more cancer types and liquid tumors will presumably make clear that an arbitrary expression of Nanog or certain Nanog retrogenes might be a universal mechanism for cancer cells to generate pluriopotency.
Nanog -in combination with Oct4 and Sox2 -initiates a genetic program that allows embryonic stem cells to self-renew and to block differentiation processes (Ivanova et al., 2006) . Recently, this 'core Nanog network' has been unraveled (Boyer et al., 2005) . The core Nanog network controls about 350 genes, of which about 100 are transcription factors. As the activated genes of the core Nanog network confer stemness, it is plausible that t(4;11) cells exhibiting Nanog-and Oct4-like activities may induce self-renewal in a similar fashion.
To verify these findings for t(4,11) leukemia, we analysed the transcription of several Nanog/Oct4 target genes in biopsy material of t(4;11) patients. As shown in Figure 6 , adult and infant t(4;11) patient cells actively transcribe Nanog, Oct4 and Bmi1, respectively. Several target genes of the core Nanog network like Stat3, Myst3, REST and ZFP36L1 are consistently transcribed. This indicates that Nanog-and Oct4-derived activities are present in the analysed t(4;11) leukemia cells.
By contrast, Meis1 and Fli1, two genes that are normally repressed by PRC2 (Lee et al., 2006) , were actively transcribed in all investigated t(4;11) biopsy probes. This may indicate that specific Nanog/Oct4 target genes may be deregulated in the presence of the t(4;11) fusion proteins. As a matter of fact, 19 out of 57 repressed Nanog/Oct4 target genes are also primary targets of the MLL protein (ATBF1, DLX5, EN1, FLI1, FOXA2, FOXD3, GBX2, GLI3, HOXB3, HOXC4, INSM1, IPF1, LHX2, MEIS1, NR4A2, NR6A1, RORB, SOX5, TBX5; Guenther et al., 2005) . Thus, the presence of the t(4;11) fusion proteins may counteract the transcriptional repression of Fli1 and Meis1. The transcriptional properties of all transcription factors regulated by the core Nanog network are currently investigated to unravel the extent of deregulated target genes.
Another interesting observation is the overexpression of HoxA7 and HoxA10, but not of HoxA9 in MLL . AF4-transfected cells. HoxA9 is the major target gene that is transcriptionally activated by many different MLL fusion proteins such as MLL . ENL, MLL . AF6, MLL . AF10, MLL . ELL and MLL . CBP (Ayton and Cleary, 2003) . However, overexpression of HoxA7 and HoxA9 is always correlated with AML. We analysed MLL fusion proteins associated with an ALL disease phenotype. In a recent study comparing gene expression profiles of acute lymphoblastic leukemia patients, a HoxA7/HoxA10 signature was identified in MLL-rearranged ALL when compared with other B-lineage ALL or AML (Andersson et al., 2005; Supplementary Tables 21-23 ). Noteworthy, co-transfected cells lost this Hox signature, but showed an upregulation of the homeobox gene Nanog.
The latter finding points to a mechanism where the presence of the MLL . AF4 fusion protein or both reciprocal t(4;11) fusion proteins may be of critical importance. If both reciprocal MLL fusion proteins are expressed, a 'stem cell-like program' will be induced, whereas the overexpression of the MLL . AF4 fusion protein alone is able to initiate the 'Hox program'. This interpretation solves the controversial situation found for 20% of t(4;11) leukemia patients, where only the presence of the MLL . AF4 fusion allele was successfully verified Janssen et al., 1994; Reichel et al., 2001 ). In both genetic situations selfrenewal would be granted, either by a Nanog-dependent 'stem cell program' or by HoxA genes in conjunction with Meis1. As overexpressed AF4 . MLL fusion protein confers sensitivity against apoptosis, downregulation or deletion of this fusion gene might even be a selective advantage for leukemic cells.
In conclusion, we were able to demonstrate for the first time that the pathological disease mechanism of t(4;11) leukemia depends on the combined biological properties of both reciprocal MLL fusion proteins. To verify this finding, retroviral transduction experiments of murine hematopoietic stem cells are currently underway to unravel the genetic prerequisites for t(4;11) leukemia. Only these in vivo experiments will finally answer the interesting question whether one or both of the t(4;11) fusion proteins will be sufficient and necessary to establish leukemia in an animal model system.
Materials and methods

Patient material
Total RNA was isolated from bone marrow and/or peripheral blood samples of t(4;11) patients and cDNA syntheses were performed. Informed consent was obtained from all patients or patients' parents/legal guardians and control individuals.
Cloning of cDNA expression constructs
The cDNA cassettes coding for MLL . AF4 (der11) and AF4 . MLL (der4) have been described (Bursen et al., 2004) . To establish the MEF/tTAHder4 and MEF/ tTAHder 11 cell lines, selection was started 48 h after transfection with 300 mg/ml hygromycin or 3 mg/ml puromycin, respectively. Using two antibiotics, a co-transfected cell line containing both conditional cDNA cassettes was established (MEF/tTAHder4/11). Single clones were established for each line and tested by reverse transcription (RT)-PCR experiments for their ability to induce transgene expression. All transgenes were suppressed by adding 10 mg/ml doxycycline to the media. For each experiment described below, the expression of all transgenes was induced by culturing the stably transfected cell lines for 5 days in the absence of any doxycycline.
RT-PCR experiments
For RT-PCR experiments, RNA was isolated using the RNeasy Kit (Qiagen, Hilden, Germany) and the RNase free DNase Kit (Qiagen), according to the manufacturer's recommendations. One microgram RNA was reverse transcribed into cDNA using superscript reverse transcriptase (Invitrogen, Karlsruhe, Germany) following the manufacturer's instructions. cDNA from patient samples was obtained from t(4;11) patients and used for analyses. For RT-PCR experiments we used the following oligonucleotides: MLL . AF4: Quantitative RT-PCR experiments were performed using the Mini-Opticon-Cycler (Biorad, Munich, Germany) and Sybrgreen Mix (Biorad) according to the manufacturer's instructions. All experiments were performed in triplicates. GAPDH served as an internal standard to normalize the gene expression levels. The following primers were used: Bak . 
Focus formation experiments
For focus formation assays, 1 Â 10 4 cells were seeded on 60 mm dishes (Corning). Cells were grown in DMEM supplemented with 5% FCS, 5% CS, the appropriate antibiotics and in the presence or absence of doxycycline. Culture medium was exchanged every 3 days. After 14-21 days, cells were washed once with PBS and then fixed with 3 ml of a 2% formaldehyde solution for 2 min. The dishes were rinsed with water and fixed cells were stained with 0.5 ml of a 1 mg/ml methylene blue solution for 15 min.
MTT assay
Cells were plated in triplicate at 4 Â 10 3 cells/well in a 96-well plate. Over a period of 96 h, cell proliferation was measured every 24 h by adding 20 ml MTT (MERCK, Darmstadt, Germany) in a concentration of 10 mg/ml in each well and incubating for 3 h at 371C. The supernatant was removed and the precipitate was solubilized with 100 ml DMSO (100%) per well and the absorption was measured at 450 nm using an ELISA reader (Pegasus Scientific, MD, USA). All experiments were repeated five times.
Analysis of apoptosis and cell cycle by flow cytometry For cell cycle analysis and apoptosis measurements, the FITC BrdU Flow Kit (BD Pharmingen, Heidelberg, Germany) was used. Cells treated as indicated above were pulse-labeled with 10 mM BrdU for 30 min, fixed, permeabilized and stained with anti-BrdU-FITC and 7-AAD according to the manufacturer's instructions. At least 10 4 cells were analysed by flow cytometry (FACScalibur and CellQuest Software, Becton Dickinson, Heidelberg, Germany). Cells with DNA content oG1 were scored as apoptotic. Cell cycle analysis was performed excluding cells with DNA content oG1 and >G2. All experiments were performed in triplicate and repeated three times.
Gene expression profiling experiments
Total RNA was isolated from untransfected and stably transfected cell lines on 3 independent days, mixed and used for hybridization of Mouse Genome 430 2.0. arrays. All experiments were replicated twice in order to identify up-and downregulated genes. Gene lists were created by using only significantly changed t(4;11) pathobiology A Gaussmann et al gene signatures (D>2-fold). All Affymetrix experiments were performed on the NGFN II Affymetrix working platform in Essen (L Klein-Hitpass). Comparison analysis was performed by using the FileMaker database program.
